The Alliance for Clinical Research Excellence and Safety (ACRES) announced the launch of ACRES BlueCloud™
The Alliance for Clinical Research Excellence and Safety (ACRES) announced the launch of ACRES BlueCloud™, the first phase implementation of a shared multi-user interface to allow sponsors, CROs, regulatory agencies, funding agencies and IRBs to access verifiable professional experience and training credentials, for sharing and mutual recognition credentials by multiple stakeholders.
The technology also provides a global integration platform through which stakeholders can access and deploy already established technology solutions and collaborative data warehouses to support a global system for high-performance Accountable Research™. ACRES’ strategic ally HealthCarePoint, a Texas-based healthcare and clinical research networking-technology corporation, provides the ACRES BlueCloud™capabilities. HealthCarePoint is among several technology companies and standards organizations comprising ACRES’ global Technology Consortium. Rollout of the ACRES Blue Cloud™ platform will begin immediately by providing the technology free of charge to clinical research sites worldwide, thereby extending and leveraging the existing global network of nearly three-quarter million current BlueCloud™ users from some 60,000 healthcare and research-related organizations worldwide. The network’s single sign-on interface will allow sites to connect with sponsors, CROs, ethics committees (IRBs) and other stakeholders through a unified platform, sharing critical professional and operational information, such as GCP training certifications and other professional credentials. As other provider technologies integrate with the shared platform through application programming interfaces, commonly known as APIs, additional functionality will be added.
Read the full release here.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
2 Commerce Drive
Cranbury, NJ 08512